An in-depth analysis of IC50 fingerprints produced in this panel by SJ3149 and 120 other anti-cancer agents revealed a significant correlation with MDM2 inhibitor Nutlin-3a (Fig. 3e)44. This evidence concerns the gene MDM2 and cancer.